Botox
![Revance Daxxify price cut, Daxxify vs Botox comparison, Daxxify cosmetic dermal filler, Botox market share 2023, Daxxify FDA approval, Daxxify cervical dystonia treatment, Revance stock price RVNC](https://pharmtales.com/wp-content/uploads/2023/09/Revance-slashes-Daxxifys-price-to-compete-with-AbbVies-Botox-in-the-cosmetic-market.jpg)
Revance slashes Daxxify’s price to compete with AbbVie’s Botox in the cosmetic market
Anika Sharma
Nashville-based company Revance had high hopes for its new cosmetic dermal filler, Daxxify, which boasted a longevity twice that of ...
![Evolus, Botox, Jeuveau, AbbVie](https://pharmtales.com/wp-content/uploads/2023/08/Jeuveau_-The-gender-inclusive-cosmetic-injectable-that-rivals-Botox.jpg)
Jeuveau: The gender-inclusive cosmetic injectable that rivals Botox
SG Tylor
Evolus is revolutionizing its approach to promoting its Botox alternative. The previous campaign had been contributing to impressive growth for ...